Thomas W. Beetham, EVP & Chief Legal Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 59 shares at $18.58 ($1K) on 2020-02-14, disclosed to the SEC on 2020-02-19.
Scheduled sale ($1k) by EVP & Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| KNSA | SELL | 2021-02-05 | $109K | — | Filing → |
| KNSA | SELL | 2020-07-02 | $1.5M | — | Filing → |
| KNSA | SELL | 2020-06-12 | $690K | — | Filing → |